Global and United States Nanomedicines Market Report & Forecast 2024-2031

Report ID: 1860700 | Published Date: Jan 2025 | No. of Page: 96 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Nanomedicines Revenue in Nanomedicines Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Nanomedicines Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Nanomedicines Market Size for the Year 2017-2028
        1.2.2 Global Nanomedicines Market Size for the Year 2017-2028
    1.3 Nanomedicines Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Nanomedicines in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Nanomedicines Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Nanomedicines Market Dynamics
        1.4.1 Nanomedicines Industry Trends
        1.4.2 Nanomedicines Market Drivers
        1.4.3 Nanomedicines Market Challenges
        1.4.4 Nanomedicines Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Nanomedicines by Type
    2.1 Nanomedicines Market Segment by Type
        2.1.1 Nanoparticles
        2.1.2 Nanoshells
        2.1.3 Nanotubes
        2.1.4 Nanodevices
        2.1.5 Others
    2.2 Global Nanomedicines Market Size by Type (2017, 2022 & 2028)
    2.3 Global Nanomedicines Market Size by Type (2017-2028)
    2.4 United States Nanomedicines Market Size by Type (2017, 2022 & 2028)
    2.5 United States Nanomedicines Market Size by Type (2017-2028)
3 Nanomedicines by Application
    3.1 Nanomedicines Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Clinics
        3.1.3 Research Institute
    3.2 Global Nanomedicines Market Size by Application (2017, 2022 & 2028)
    3.3 Global Nanomedicines Market Size by Application (2017-2028)
    3.4 United States Nanomedicines Market Size by Application (2017, 2022 & 2028)
    3.5 United States Nanomedicines Market Size by Application (2017-2028)
4 Global Nanomedicines Competitor Landscape by Company
    4.1 Global Nanomedicines Market Size by Company
        4.1.1 Top Global Nanomedicines Companies Ranked by Revenue (2021)
        4.1.2 Global Nanomedicines Revenue by Player (2017-2022)
    4.2 Global Nanomedicines Concentration Ratio (CR)
        4.2.1 Nanomedicines Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Nanomedicines in 2021
        4.2.3 Global Nanomedicines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Nanomedicines Headquarters, Revenue in Nanomedicines Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Nanomedicines Headquarters and Area Served
        4.3.2 Global Nanomedicines Companies Revenue in Nanomedicines Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Nanomedicines Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Nanomedicines Market Size by Company
        4.5.1 Top Nanomedicines Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Nanomedicines Revenue by Players (2020, 2021 & 2022)
5 Global Nanomedicines Market Size by Region
    5.1 Global Nanomedicines Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Nanomedicines Market Size by Region (2017-2028)
        5.2.1 Global Nanomedicines Market Size by Region: 2017-2022
        5.2.2 Global Nanomedicines Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Nanomedicines Market Size YoY Growth 2017-2028
        6.1.2 North America Nanomedicines Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Nanomedicines Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Nanomedicines Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Nanomedicines Market Size YoY Growth 2017-2028
        6.3.2 Europe Nanomedicines Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Nanomedicines Market Size YoY Growth 2017-2028
        6.4.2 Latin America Nanomedicines Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Nanomedicines Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Nanomedicines Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Company Details
        7.1.2 Abbott Business Overview
        7.1.3 Abbott Nanomedicines Introduction
        7.1.4 Abbott Revenue in Nanomedicines Business (2017-2022)
        7.1.5 Abbott Recent Development
    7.2 GE Healthcare
        7.2.1 GE Healthcare Company Details
        7.2.2 GE Healthcare Business Overview
        7.2.3 GE Healthcare Nanomedicines Introduction
        7.2.4 GE Healthcare Revenue in Nanomedicines Business (2017-2022)
        7.2.5 GE Healthcare Recent Development
    7.3 Johnson & Johnson
        7.3.1 Johnson & Johnson Company Details
        7.3.2 Johnson & Johnson Business Overview
        7.3.3 Johnson & Johnson Nanomedicines Introduction
        7.3.4 Johnson & Johnson Revenue in Nanomedicines Business (2017-2022)
        7.3.5 Johnson & Johnson Recent Development
    7.4 Merck
        7.4.1 Merck Company Details
        7.4.2 Merck Business Overview
        7.4.3 Merck Nanomedicines Introduction
        7.4.4 Merck Revenue in Nanomedicines Business (2017-2022)
        7.4.5 Merck Recent Development
    7.5 Pfizer
        7.5.1 Pfizer Company Details
        7.5.2 Pfizer Business Overview
        7.5.3 Pfizer Nanomedicines Introduction
        7.5.4 Pfizer Revenue in Nanomedicines Business (2017-2022)
        7.5.5 Pfizer Recent Development
    7.6 CombiMatrix
        7.6.1 CombiMatrix Company Details
        7.6.2 CombiMatrix Business Overview
        7.6.3 CombiMatrix Nanomedicines Introduction
        7.6.4 CombiMatrix Revenue in Nanomedicines Business (2017-2022)
        7.6.5 CombiMatrix Recent Development
    7.7 Celgene
        7.7.1 Celgene Company Details
        7.7.2 Celgene Business Overview
        7.7.3 Celgene Nanomedicines Introduction
        7.7.4 Celgene Revenue in Nanomedicines Business (2017-2022)
        7.7.5 Celgene Recent Development
    7.8 Mallinckrodt
        7.8.1 Mallinckrodt Company Details
        7.8.2 Mallinckrodt Business Overview
        7.8.3 Mallinckrodt Nanomedicines Introduction
        7.8.4 Mallinckrodt Revenue in Nanomedicines Business (2017-2022)
        7.8.5 Mallinckrodt Recent Development
    7.9 Sigma-Tau Pharmaceuticals
        7.9.1 Sigma-Tau Pharmaceuticals Company Details
        7.9.2 Sigma-Tau Pharmaceuticals Business Overview
        7.9.3 Sigma-Tau Pharmaceuticals Nanomedicines Introduction
        7.9.4 Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2017-2022)
        7.9.5 Sigma-Tau Pharmaceuticals Recent Development
    7.10 Teva Pharmaceutical
        7.10.1 Teva Pharmaceutical Company Details
        7.10.2 Teva Pharmaceutical Business Overview
        7.10.3 Teva Pharmaceutical Nanomedicines Introduction
        7.10.4 Teva Pharmaceutical Revenue in Nanomedicines Business (2017-2022)
        7.10.5 Teva Pharmaceutical Recent Development
    7.11 Nanosphere
        7.11.1 Nanosphere Company Details
        7.11.2 Nanosphere Business Overview
        7.11.3 Nanosphere Nanomedicines Introduction
        7.11.4 Nanosphere Revenue in Nanomedicines Business (2017-2022)
        7.11.5 Nanosphere Recent Development
    7.12 UCB SA
        7.12.1 UCB SA Company Details
        7.12.2 UCB SA Business Overview
        7.12.3 UCB SA Nanomedicines Introduction
        7.12.4 UCB SA Revenue in Nanomedicines Business (2017-2022)
        7.12.5 UCB SA Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Nanomedicines Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Nanomedicines Market Trends
    Table 3. Nanomedicines Market Drivers
    Table 4. Nanomedicines Market Challenges
    Table 5. Nanomedicines Market Restraints
    Table 6. Global Nanomedicines Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Nanomedicines Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Nanomedicines Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Nanomedicines Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Nanomedicines Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Nanomedicines Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Nanomedicines Revenue Share by Player, 2017-2022
    Table 13. Global Nanomedicines Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Nanomedicines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicines as of 2021)
    Table 15. Top Players of Nanomedicines in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Nanomedicines Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Nanomedicines Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Nanomedicines Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Nanomedicines Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Nanomedicines Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Nanomedicines Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Nanomedicines Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Nanomedicines Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Nanomedicines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Nanomedicines Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Nanomedicines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Nanomedicines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Nanomedicines Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Abbott Company Details
    Table 31. Abbott Business Overview
    Table 32. Abbott Nanomedicines Product
    Table 33. Abbott Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 34. Abbott Recent Development
    Table 35. GE Healthcare Company Details
    Table 36. GE Healthcare Business Overview
    Table 37. GE Healthcare Nanomedicines Product
    Table 38. GE Healthcare Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 39. GE Healthcare Recent Development
    Table 40. Johnson & Johnson Company Details
    Table 41. Johnson & Johnson Business Overview
    Table 42. Johnson & Johnson Nanomedicines Product
    Table 43. Johnson & Johnson Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 44. Johnson & Johnson Recent Development
    Table 45. Merck Company Details
    Table 46. Merck Business Overview
    Table 47. Merck Nanomedicines Product
    Table 48. Merck Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 49. Merck Recent Development
    Table 50. Pfizer Company Details
    Table 51. Pfizer Business Overview
    Table 52. Pfizer Nanomedicines Product
    Table 53. Pfizer Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 54. Pfizer Recent Development
    Table 55. CombiMatrix Company Details
    Table 56. CombiMatrix Business Overview
    Table 57. CombiMatrix Nanomedicines Product
    Table 58. CombiMatrix Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 59. CombiMatrix Recent Development
    Table 60. Celgene Company Details
    Table 61. Celgene Business Overview
    Table 62. Celgene Nanomedicines Product
    Table 63. Celgene Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 64. Celgene Recent Development
    Table 65. Mallinckrodt Company Details
    Table 66. Mallinckrodt Business Overview
    Table 67. Mallinckrodt Nanomedicines Product
    Table 68. Mallinckrodt Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 69. Mallinckrodt Recent Development
    Table 70. Sigma-Tau Pharmaceuticals Company Details
    Table 71. Sigma-Tau Pharmaceuticals Business Overview
    Table 72. Sigma-Tau Pharmaceuticals Nanomedicines Product
    Table 73. Sigma-Tau Pharmaceuticals Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 74. Sigma-Tau Pharmaceuticals Recent Development
    Table 75. Teva Pharmaceutical Company Details
    Table 76. Teva Pharmaceutical Business Overview
    Table 77. Teva Pharmaceutical Nanomedicines Product
    Table 78. Teva Pharmaceutical Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 79. Teva Pharmaceutical Recent Development
    Table 80. Nanosphere Company Details
    Table 81. Nanosphere Business Overview
    Table 82. Nanosphere Nanomedicines Product
    Table 83. Nanosphere Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 84. Nanosphere Recent Development
    Table 85. UCB SA Company Details
    Table 86. UCB SA Business Overview
    Table 87. UCB SA Nanomedicines Product
    Table 88. UCB SA Revenue in Nanomedicines Business (2017-2022) & (US$ Million)
    Table 89. UCB SA Recent Development
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Nanomedicines Product Picture
    Figure 2. Global Nanomedicines Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Nanomedicines Market Size 2017-2028 (US$ Million)
    Figure 4. United States Nanomedicines Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Nanomedicines Market Size 2017-2028 (US$ Million)
    Figure 6. United States Nanomedicines Market Share in Global 2017-2028
    Figure 7. Nanomedicines Report Years Considered
    Figure 8. Product Picture of Nanoparticles
    Figure 9. Product Picture of Nanoshells
    Figure 10. Product Picture of Nanotubes
    Figure 11. Product Picture of Nanodevices
    Figure 12. Product Picture of Others
    Figure 13. Global Nanomedicines Market Share by Type in 2022 & 2028
    Figure 14. Global Nanomedicines Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. Global Nanomedicines Market Share by Type (2017-2028)
    Figure 16. United States Nanomedicines Market Share by Type in 2022 & 2028
    Figure 17. United States Nanomedicines Market Size by Type (2017-2028) & (US$ Million)
    Figure 18. United States Nanomedicines Market Share by Type (2017-2028)
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Clinics
    Figure 21. Product Picture of Research Institute
    Figure 22. Global Nanomedicines Market Share by Application in 2022 & 2028
    Figure 23. Global Nanomedicines Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Nanomedicines Market Share by Application (2017-2028)
    Figure 25. United States Nanomedicines Market Share by Application in 2022 & 2028
    Figure 26. United States Nanomedicines Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Nanomedicines Market Share by Application (2017-2028)
    Figure 28. North America Nanomedicines Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Nanomedicines Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Nanomedicines Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Nanomedicines Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Nanomedicines Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. UAE Nanomedicines Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Abbott Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 57. GE Healthcare Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 58. Johnson & Johnson Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 59. Merck Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 60. Pfizer Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 61. CombiMatrix Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 62. Celgene Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 63. Mallinckrodt Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 64. Sigma-Tau Pharmaceuticals Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 65. Teva Pharmaceutical Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 66. Nanosphere Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 67. UCB SA Revenue Growth Rate in Nanomedicines Business (2017-2022)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
GE Healthcare
Johnson & Johnson
Merck
Pfizer
CombiMatrix
Celgene
Mallinckrodt
Sigma-Tau Pharmaceuticals
Teva Pharmaceutical
Nanosphere
UCB SA
Frequently Asked Questions
Nanomedicines report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Nanomedicines report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Nanomedicines report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Nanoparticles

Nanoparticles market is segmented by region (country), players, by Type and by Application. Playe ... Read More

Nanotube Electronics

Nanotube Electronics market is segmented by region (country), players, by Type and by Application ... Read More